HomeCompareUELKY vs MRK

UELKY vs MRK: Dividend Comparison 2026

UELKY yields 7.64% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UELKY wins by $76690.11M in total portfolio value
10 years
UELKY
UELKY
● Live price
7.64%
Share price
$27.00
Annual div
$2.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$76690.17M
Annual income
$74,808,536,165.81
Full UELKY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — UELKY vs MRK

📍 UELKY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUELKYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UELKY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UELKY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UELKY
Annual income on $10K today (after 15% tax)
$649.19/yr
After 10yr DRIP, annual income (after tax)
$63,587,255,740.94/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, UELKY beats the other by $63,587,247,412.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UELKY + MRK for your $10,000?

UELKY: 50%MRK: 50%
100% MRK50/50100% UELKY
Portfolio after 10yr
$38345.11M
Annual income
$37,404,272,981.97/yr
Blended yield
97.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

UELKY
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
2.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UELKY buys
0
MRK buys
0
No recent congressional trades found for UELKY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUELKYMRK
Forward yield7.64%2.76%
Annual dividend / share$2.06$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$76690.17M$56.8K
Annual income after 10y$74,808,536,165.81$9,798.13
Total dividends collected$76561.43M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: UELKY vs MRK ($10,000, DRIP)

YearUELKY PortfolioUELKY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,228$1,527.51$11,206$366.19+$1.0KUELKY
2$16,575$3,491.15$12,650$502.35+$3.9KUELKY
3$26,580$8,845.44$14,407$694.19+$12.2KUELKY
4$54,955$26,514.42$16,585$967.82+$38.4KUELKY
5$161,268$102,465.75$19,342$1,363.89+$141.9KUELKY
6$734,592$562,035.10$22,913$1,947.19+$711.7KUELKY
7$5,571,297$4,785,284.25$27,662$2,823.89+$5.54MUELKY
8$73,797,916$67,836,627.45$34,159$4,173.35+$73.76MUELKY
9$1,758,534,192$1,679,570,421.98$43,337$6,308.80+$1758.49MUELKY
10$76,690,167,751$74,808,536,165.81$56,776$9,798.13+$76690.11MUELKY

UELKY vs MRK: Complete Analysis 2026

UELKYStock

Ülker Bisküvi Sanayi A.S., together with its subsidiaries, engages in the manufacture, marketing, and sale of biscuits, chocolates, chocolate coated biscuits, cakes, wafers, and crackers in Turkey and internationally. The company also produces chocolate dough, cocoa powder, chocolate drop, chocolate flakes, couverture chocolate, flour, hazelnut, and pureed hazelnut. In addition, it is also involved in the trading and investment activities. The company offers its products under the various company owned brands, as well as private labels. It also exports its products to the Middle East, Russia, Central Asian republics, Europe, Africa, and the United States. The company was founded in 1944 and is headquartered in Istanbul, Turkey. Ülker Bisküvi Sanayi A.S. is a subsidiary of pladis Foods Limited.

Full UELKY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this UELKY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UELKY vs SCHDUELKY vs JEPIUELKY vs OUELKY vs KOUELKY vs MAINUELKY vs JNJUELKY vs ABBVUELKY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.